Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohnʼs Disease

Lee, Dale, Baldassano, Robert N., Otley, Anthony R., Albenberg, Lindsey, Griffiths, Anne M., Compher, Charlene, Chen, Eric Z., Li, Hongzhe, Gilroy, Erin, Nessel, Lisa, Grant, Amy, Chehoud, Christel, Bushman, Frederic D., Wu, Gary D., Lewis, James D. · 2015 · Inflammatory Bowel Diseases

Abstract

BACKGROUND: Therapeutic targets in pediatric Crohn's disease include symptoms, quality of life (QOL), and mucosal healing. Although partial enteral nutrition (PEN), exclusive enteral nutritional (EEN), and anti-tumor necrosis factor alpha (anti-TNF) therapy all improve symptoms, the comparative effectiveness of these approaches to improve QOL and achieve mucosal healing has not been assessed prospectively. METHODS: In a prospective study of children initiating PEN, EEN, or anti-TNF therapy for Crohn's disease, we compared clinical outcomes using the Pediatric Crohn's Disease Activity Index (PCDAI), QOL (IMPACT score), and mucosal healing as estimated by fecal calprotectin (FCP). PCDAI, IMPACT, FCP, and diet (prompted 24-h recall) were measured at baseline and after 8 weeks of therapy. RESULTS: We enrolled 90 children with active Crohn's disease (PCDAI, 33.7 ± 13.7; and FCP, 976 ± 754), of whom 52 were treated with anti-TNF, 22 with EEN, and 16 with PEN plus ad lib diet. Clinical response (PCDAI reduction ≥15 or final PCDAI ≤10) was achieved by 64% on PEN, 88% EEN, and 84% anti-TNF (test for trend P = 0.08). FCP ≤250 μg/g was achieved with PEN in 14%, EEN 45%, and anti-TNF 62% (test for trend P = 0.001). Improvement in overall QOL was not statistically significantly different between the 3 groups (P = 0.86). However, QOL improvement was the greatest with EEN in the body image (P = 0.03) domain and with anti-TNF in the emotional domain (P = 0.04). CONCLUSIONS: Although PEN improved clinical symptoms, EEN and anti-TNF were more effective for decreasing mucosal inflammation and improving specific aspects of QOL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mib.0000000000000426

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 171

Metadata

Authors
Lee, D., Baldassano, R. N., Otley, A. R., Albenberg, L., Griffiths, A. M., Compher, C., Chen, E. Z., Li, H., Gilroy, E., Nessel, L., Grant, A., Chehoud, C., Bushman, F. D., Wu, G. D., & Lewis, J. D.
Venue
Inflammatory Bowel Diseases
Published
2015-08
Volume
21
Issue
8
Pages
1786-1793
ISSN
1078-0998 (ISSN-L)
OpenAlex
W293546233
Cited by
171
References
2
FWCI
10.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohnʼs Disease. https://app.cochat.ai/papers/10.1097/mib.0000000000000426
The paper
Lee, D., Baldassano, R. N., Otley, A. R., Albenberg, L., Griffiths, A. M., Compher, C., Chen, E. Z., Li, H., Gilroy, E., Nessel, L., Grant, A., Chehoud, C., Bushman, F. D., Wu, G. D., & Lewis, J. D. (2015). Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohnʼs Disease. Inflammatory Bowel Diseases. https://doi.org/10.1097/mib.0000000000000426

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.